Concentrate of Autologous Rich Plasma in Growth Factors in the Treatment of the Thin Endometrium

  • STATUS
    Recruiting
  • End date
    Mar 30, 2022
  • participants needed
    12
  • sponsor
    Sara Rafael Fernandez
Updated on 2 August 2021

Summary

This study evaluate the percentage of women with thin endometrium who achieve an endometrial thickness equal to or greater than 7 mm after administration of PRGF (plasma rich in growth factors)

Details
Condition Female Genital Diseases, Infertility, Female infertility, Gynecological Infections, sterility, unable to conceive
Treatment Plasma rich in growth factors (PRGF-Endoret)
Clinical Study IdentifierNCT03387501
SponsorSara Rafael Fernandez
Last Modified on2 August 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Women who signed informed consent
Women who understand the Spanish language
Women under 42 years

Exclusion Criteria

Thrombopenia
Congenital or acquired uterine malformations that reduce embryo implantation or term gestation
Ovarian tumors
Benign uterine tumors require surgical treatment
Local acute inflammatory diseases
Patients with malignant tumors requiring chemotherapy
Patients with acute or chronic infectious or inflammatory diseases requiring active treatment with drugs that may interfere with implantation and gestation
Chronic treatment with NSAIDs (Nonsteroidal anti-inflammatory drugs)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note